Covista Inc. (CVSA)
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
- Symbol
- CVSA
- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Market cap
- $4.22B
- 52 week range
- 86.97 - 156.26
Valuation
- Share price
- $123.19 (close of 2026-09-23)
- P/E (TTM)
- 17.25x
- Price to book
- 2.92x
- Price to free cash flow
- 10.74x
- Enterprise value
- $4.72B
- Book value per share
- $42.49
Price performance
| Period | Change |
|---|
| 1 day | -2.07% |
| 5 days | -2.45% |
| 1 month | -6.92% |
| 3 months | +2.04% |
| 6 months | +12.36% |
| Year to date | +19.06% |
| 1 year | -14.50% |
| 3 years | +187.49% |
| 5 years | +219.97% |
| 10 years | +449.22% |
| All time | +9997.54% |
Profitability and growth
- Return on equity
- 17.40%
- Return on invested capital
- 15.71%
- Return on assets
- 8.35%
- Return on capital employed
- 15.87%
- Gross margin
- 57.34%
- Net margin
- 12.87%
- EBITDA margin
- 21.86%
- Revenue growth
- 9.27%
- Net income growth
- 6.12%
- Free cash flow growth
- 36.57%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 9.32%
- Current ratio
- 1.09x
- Net debt to EBITDA
- 1.07x
Latest reported year
- Period end
- 2026-06-30
- Fiscal year
- 2026
- Revenue
- $1.95B
- Cost of revenue
- $833.66M
- Gross profit
- $1.12B
- EBITDA
- $427.23M
- Net income
- $251.57M
- Earnings per share
- $7.18
- Interest expense
- $45.44M
- Shares outstanding
- 35.05M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2026-06-30 | $1.95B | $1.12B | $251.57M | $7.18 |
| 2025-06-30 | $1.79B | $1.02B | $237.06M | $6.39 |
| 2024-06-30 | $1.58B | $886.10M | $136.78M | $3.47 |
| 2023-06-30 | $1.45B | $802.34M | $93.36M | $2.08 |
| 2022-06-30 | $1.38B | $722.07M | $310.99M | $6.43 |
| 2021-06-30 | $899.25M | $441.34M | $70.03M | $1.36 |
| 2020-06-30 | $866.43M | $409.26M | $-85.33M | $-1.59 |
| 2019-06-30 | $1.01B | $542.06M | $95.17M | $1.63 |
| 2018-06-30 | $960.28M | $498.72M | $33.77M | $0.55 |
| 2017-06-30 | $1.21B | $569.66M | $122.28M | $1.93 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2026-06-30 | 57.34% | 12.87% | 17.40% | 15.71% |
| 2025-06-30 | 56.86% | 13.26% | 16.54% | 13.73% |
| 2024-06-30 | 55.92% | 8.63% | 9.99% | 9.55% |
| 2023-06-30 | 55.30% | 6.43% | 6.41% | 7.59% |
| 2022-06-30 | 52.25% | 22.51% | 20.85% | 3.47% |
| 2021-06-30 | 49.08% | 7.79% | 5.41% | 4.65% |
| 2020-06-30 | 47.24% | -9.85% | -6.52% | 8.30% |
| 2019-06-30 | 53.47% | 9.39% | 6.84% | 7.74% |
| 2018-06-30 | 51.94% | 3.52% | 2.22% | - |
| 2017-06-30 | 47.16% | 10.12% | 7.33% | - |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2026-06-30 | $406.32M | $657.75M |
| 2025-06-30 | $199.60M | $552.67M |
| 2024-06-30 | $219.31M | $648.71M |
| 2023-06-30 | $272.19M | $695.08M |
| 2022-06-30 | $346.97M | $838.91M |
| 2021-06-30 | $476.38M | $1.07B |
| 2020-06-30 | $500.52M | $286.12M |
| 2019-06-30 | $204.20M | $398.09M |
| 2018-06-30 | $430.69M | $290.07M |
| 2017-06-30 | $240.43M | $125.00M |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2026-06-30 | $392.73M | $41.22M |
| 2025-06-30 | $287.57M | $41.59M |
| 2024-06-30 | $246.88M | $25.95M |
| 2023-06-30 | $165.90M | $14.30M |
| 2022-06-30 | $-20.45M | $22.61M |
| 2021-06-30 | $152.32M | $12.82M |
| 2020-06-30 | $68.09M | $13.88M |
| 2019-06-30 | $147.28M | $13.22M |
| 2018-06-30 | $192.57M | $14.50M |
| 2017-06-30 | $188.41M | $16.60M |
Dividend history
- Most recent payment
- 2016-11-30
| Payment date | Dividend per share |
|---|
| 2016-11-30 | $0.18 |
| 2016-06-01 | $0.18 |
| 2015-12-02 | $0.18 |
| 2015-06-03 | $0.18 |
| 2014-12-03 | $0.18 |
| 2014-06-04 | $0.17 |
| 2013-12-04 | $0.17 |
| 2013-06-05 | $0.17 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-10-29
- Consensus EPS estimate
- $1.90
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-06 | Jun/2026 | $1.89 |
| 2026-05-07 | - | - |
| 2026-01-28 | - | - |
| 2025-10-30 | - | - |
| 2025-08-07 | - | - |
| 2025-05-08 | - | - |
| 2025-01-30 | - | - |
| 2024-10-29 | - | - |
Filings and sources
- Company website
- covista.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Constellation Brands, Inc. (STZ) · Molson Coors Beverage Co (TAP) · Coca-Cola Co (KO) · PepsiCo Inc (PEP) · Monster Beverage Corp (MNST) · Keurig Dr Pepper Inc. (KDP) · Brown-Forman Corp (BF-B) · Walmart Inc. (WMT)
All Consumer Defensive companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades